Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas

Medicine and Dentistry

• Ganglioglioma 100%
• Pediatrics 100%
• Metastatic Melanoma 66%
• BRAF (Gene) 66%
• Mitogen-Activated Protein Kinase 66%
• Development 33%
• Neoplasm 33%
• Colon Carcinoma 33%
• Malignant Neoplasm 33%
• Cell Cycle Progression 33%
• Point Mutation 33%
• Hairy Cell Leukemia 33%
• Papillary Thyroid Cancer 33%
• Molecularly Targeted Therapy 33%
• Diagnostic Marker 33%
• Kinase 33%
• Signal Transduction 33%
• Growth Factor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Mitogen Activated Protein Kinase 100%
• Glioma 100%
• Metastatic Melanoma 100%
• Growth Factor 50%
• Malignant Neoplasm 50%
• Neoplasm 50%
• Colon Carcinoma 50%
• Hairy Cell Leukemia 50%
• Thyroid Papillary Carcinoma 50%

Biochemistry, Genetics and Molecular Biology

• Mitogen-Activated Protein Kinase 100%
• BRAF (Gene) 100%
• Colon 50%
• Signal Transduction 50%
• Molecular Biology 50%
• Growth Factor 50%
• Cell Cycle Progression 50%
• Point Mutation 50%
• Development 50%